ArticleEJNMMI research2025
Impact of biocontainment on small animal PET performance adapted for BSL-2/3 infectious disease imaging research.
Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundBiocontainment protocols are critical for conducting infectious disease (ID) research, particularly when using small animal models in biosafety level (BSL) 2/3 environments. This study evaluates the impact of poly-methyl methacrylate (PMMA) containment vessels on the performance of preclinical positron emission tomography (PET) systems. We tested containment vessels designed with varying wall thicknesses (3, 6, and 9 mm) to simulate ID imaging facility equipment and protocols. Through the use of multicomponent phantoms and in vivo mouse models of Staphylococcus aureus infection, we assessed key performance metrics including count rate, image quality, activity recovery, and spatial resolution.
resultsThe results indicate that the use of PMMA containment causes only minor reductions in imaging performance. The thickest PMMA (9 mm) led to a maximum 6.8% decrease in count rate, which remains well within the acceptable range of variation. Effects on spatial resolution were most noticeable for smaller structures within the phantom study, with a 19.65% difference in full width at half maximum (FWHM) for the thickest walled vessel. In vivo, using infected mice, the containment devices had modest effects on the task of activity concentration to be detected at the infection site, even with the thickest PMMA tube.
conclusionThese findings suggest that PMMA biocontainment vessels have small but measurable impact on preclinical PET system performance, making them a viable and cost-effective solution for conducting infectious disease imaging under BSL-2/3 conditions. Specifically, the thinnest containment (3 mm) had only minor effects on all tested parameters, suggesting it is well-suited for use in ID enclosures while maintaining accurate qualitative and quantitative assessments. This approach may reduce the burden for fully separate and specialized modifications for BSL-3 imaging facilities, and can be broadly applied to preclinical research involving pathogenic organisms.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.